section name header

Pronunciation

di-JOX-in audio

Classifications

Therapeutic Classification: antiarrhythmics, inotropics

Pharmacologic Classification: digitalis glycosides

Indications

BEERS REMS

Action

Therapeutic Effects:

Pharmacokinetics

Absorption: 60–80% absorbed after oral administration of tablets; 70–85% absorbed after administration of elixir; 80% absorbed from IM sites (IM route not recommended due to pain/irritation). IV administration results in complete bioavailability.

Distribution: Widely distributed to tissues.

Metabolism/Excretion: Excreted almost entirely unchanged by the kidneys.

Half-life: 36–48 hr (↑ in renal impairment).

Time/Action Profile

(antiarrhythmic or inotropic effects, provided that a loading dose has been given)

ROUTEONSETPEAKDURATION
PO30–120 min2–8 hr2–4 days†
IM30 min4–6 hr2–4 days†
IV5–30 min1–4 hr2–4 days†

†Duration listed is that for normal renal function; in impaired renal function, duration will be longer.

Contraind./Precautions

Contraindicated in:

Use Cautiously in:

Adv. Reactions/Side Effects

CV: bradycardia, ECG changes, ARRHYTHMIAS, heart block.

EENT: blurred vision, yellow or green vision.

GI: anorexia, nausea, vomiting, diarrhea.

Hemat: thrombocytopenia.

Neuro: fatigue, headache, weakness.

Interactions

Drug-Drug:

Drug-Natural Products:

Drug-Food:

Route/Dosage

see Calculator

For rapid effect, a larger initial loading dose should be given in several divided doses over 12–24 hr. Maintenance doses are determined for digoxin by renal function. All dosing must be evaluated by individual response. In general, doses required for atrial arrhythmias are higher than those for inotropic effect.

Availability

(Generic available)

Assessment

Lab Test Considerations: Toxicity and Overdose:

Implementation

Patient/Family Teaching

Evaluation/Desired Outcomes

US Brand Names

Lanoxin

Pill Image

digoxin_195_8939.jpg

Code

NDC Code*